Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-02-18

FDA Approved: LEVETIRACETAM — Supplemental Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved a supplemental application for LEVETIRACETAM from Bionpharma Inc., resulting in updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)